TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
CompletedN/A

Improving Walking With Heel-To-Toe Device

Introduction: The purpose of this study is to test the efficacy potential of using real-time positive auditory feedback to improve gait pattern in people with Parkinson's Disease (PD). The components of walking are commonly affected in pati

Montreal, Quebec, CanadaView details
CompletedPhase 4

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

This study aims to assess the tolerability of duloxetine, 60mg once daily, in open label fashion, in depressed patients with Parkinson's disease during 12 weeks treatment.

Ancona, Italy+12 moreView details
RecruitingN/A

Remote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's Disease

This research will develop novel and accessible way to deliver effective and customized rehab to those suffering from common and devastating neurodegenerative condition called Parkinson's disease. The investigators will examine the efficacy

Cleveland, Ohio, United StatesView details
RecruitingN/A

The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease

The study tests whether a smart shoe (NUSHU) that provides vibrotactile stimulation can improve walking speed in people with Parkinson's disease. Sixteen participants complete two short walking tests-with and without vibration-to compare ga

Zurich, Canton of Zurich, SwitzerlandView details
CompletedN/A

In-Home Care for Patients With Parkinson's Disease

Advanced Parkinson's Disease is a debilitating, costly, and understudied condition. Improving access to comprehensive, specialized, in-home patient care and caregiver support offers the potential to minimize the downward spiral of morbidity

Chicago, Illinois, United StatesView details
Completed

PA Behavior and HRQoL in Parkinson's Disease Patients Patients: Role of Social Cognitive Variables

The primary aim of the study will be to examine Social Cognitive Theory (SCT) correlates, of physical activity (PA) participation and health-related quality of life (HRQoL) in Parkinson's disease participants.

Columbus, Ohio, United StatesView details
Unknown

Biomarker Analysis for GBA Associated Parkinson's Disease

The primary aim of the study is to conclusively demonstrate the possibility of using the following molecules, α-Synuclein, LRRK2 and Parkin individually or in combination as biomarkers for Parkinson's disease (PD) progression in patients/ c

Fairfax, Virginia, United StatesView details
Unknown

Analysis of the Parameters Obtained on Stabilometric Platform in Patients With PD

Objective: To analyze different parameters in patients with Parkinson's Disease (PD) obtained through the use of a stabilometric platform and compare them with those of a control population. To interpret the data in order to find some postu

Gravedona, Como, ItalyView details
CompletedN/A

Upper Extremity Rehabilitation With Virtual Reality in Parkinson's Disease Patients

Upper extremities are the first part of the body to be affected by Parkinson's disease. Although studies have shown that virtual reality-assisted rehabilitation methods are effective on gait and balance, studies on their use for upper extre

Bolu, Merkez, Turkey (Türkiye)View details
By invitationN/A

TUS to Disrupt Pathological Oscillations

Scientists and clinicians are interested in measuring and perturbing the signals in the brain - both to better understand normal operation and explore new therapy options for disease. One example of a signal is a "brainwave," also called a

Oxford, United KingdomView details
CompletedN/A

Individualization of Music-based Cueing During Gait in Parkinson's Disease.

Spatio-temporal correction of the step is a key component of gait rehabilitation in Parkinson's disease. Walking rehabilitation techniques using visual or auditory cueing of the cadence or step length have been tested to prevent or correct

Créteil, FranceView details
CompletedN/A

GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures

Inflammation plays a central role in Parkinson's disease. The use of anti-inflammatory drugs was found to reduce the risk of PD .

Augusta, Georgia, United StatesView details
RecruitingN/A

Movement Improves Brain Health and Cognition in Parkinson's Disease

Cognitive impairment is an acknowledged feature of Parkinson's disease (PD) and often coexists with the classic motor symptoms since their onset. Cognitive symptoms of PD can be differentiated from other neurodegenerative diseases by the af

Roma, Rome, ItalyView details
RecruitingN/A

Impact of C-Mill Rehabilitation on the Gut-Brain Axis in Parkinson's Disease

The GM-REHAB-2025 study aims to evaluate the impact of physiotherapy interventions using the C-Mill treadmill, with and without semi-immersive virtual reality, on gut microbiota and metabolic parameters in patients with Parkinson's disease.

Messina, Messina, ItalyView details
Unknown

Gut Microbiota and Parkinson's Disease

Over the past decade, experimental data has suggested a complex and bidirectional interaction between the gastrointestinal (GI) tract and the central nervous system (CNS), the so-called "Gut- Brain axis." . Changes in the gut microbiota com

Multiple locationsView details
UnknownPhase 2

Kinematic-based BoNT-A Bilateral Upper Limb PD Therapy

The primary objective is to study the efficacy of botulinum toxin type A (BoNT-A) injected via kinematic parameters in the treatment of unilateral/bilateral upper extremity tremor in Parkinson's disease (PD) tremor. Kinematic assessment too

London, Ontario, CanadaView details
CompletedPhase 1

Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy

Patients with Parkinson's Disease or Multiple System Atrophy (MSA), and symptoms of orthostatic hypotension, are eligible for the study. Each patient will have three weeks of conservative therapy, three weeks of therapy with fludrocortisone

Brisbane, Queensland, AustraliaView details
By invitationN/A

TMS in Anxiety-Parkinson's Disease

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's dementia. Anxiety in PD is common, has major effects on quality of life and contributes to increased disability.

Saint Paul, Minnesota, United StatesView details
Unknown

Precision Medical Diagnosis for Parkinson's Disease - The Quantitative Analysis System for PET/MRI Images in Patients

In nuclear medicine PET examinations, labeled radiopharmaceuticals are possible to enter the putamen and caudate nucleus regions of the striatum in the brain by intravenous injection. The severity of Parkinson's disease is assessed and diag

Multiple locationsView details
Not yet recruitingN/A

VC/VS for Apathy in PD

Apathy is a disabling neuropsychiatric symptom marked by reduced goal-directed behavior, including diminished interest, motivation, emotional expression, and social engagement. Though not formally defined in the DSM-V, apathy is common in s

Houston, Texas, United StatesView details
Load more trials